TrialNature medicine2026
Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy.
Olivia Kim-McManus et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it